BioPharma Credit PLC (FRA:B3P)

Germany flag Germany · Delayed Price · Currency is EUR
0.8200
+0.0050 (0.61%)
At close: Mar 27, 2026
Market Cap919.40M -2.3%
Revenue (ttm)134.35M +5.1%
Net Income110.62M +6.3%
EPS0.10 +14.0%
Shares Outn/a
PE Ratio8.31
Forward PEn/a
Dividend0.07 (8.51%)
Ex-Dividend DateFeb 19, 2026
Volumen/a
Average Volume164
Open0.8200
Previous Close0.8150
Day's Range0.8200 - 0.8200
52-Week Range0.6900 - 0.8750
Betan/a
RSI55.02
Earnings DateMar 24, 2026

About BioPharma Credit

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. The company debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in Leeds, the United Kingdom. [Read more]

Industry Unit Investment Trusts, Face-Amount Certificate Offices, and Closed-End Management Investment Offices
Founded 2016
Country United Kingdom
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol B3P

Financial Performance

In 2025, BioPharma Credit's revenue was $157.75 million, an increase of 5.14% compared to the previous year's $150.03 million. Earnings were $129.89 million, an increase of 6.31%.

Financial numbers in USD Financial Statements